We are inviting you to take part in the Participant Research Experience Survey (PRES). This survey provides an opportunity for those who have taken part in research to share their experience which helps us to inform future planning. The survey results also help us with informing key stakeholders about the benefits of taking part in research.
PRES 2020/21 is now a standardised survey across all CRN networks so for the first time we will be able to take part in national benchmarking.
The survey is now live via this link: https://www.surveymonkey.co.uk/r/X7RD9ZG
You will see from the last year’s results that primary care research teams in the North West Coast have made a significant and positive impact on those who have taken part in research. The results can be viewed by clicking here.
Thank you for supporting PRES
A few months ago The National Institute for Health Research asked for feedback on the patient of clinical research taking place in the NHS.
Thank you to all those that took part, your responses will help improve the way clinical research is delivered in the NHS. You can view the final report below.
We are currently inviting people to help with the following research studies.
AF – GEN observational Study
If you have Atrial fibrillation and were diagnosed in the last 12 months then you are eligible for this study.
If you are eligible, your GP or Nurse may give you a patient information sheet when you attend for your next routine appointment. However, if you meet the above criteria and are interested in helping us, you can contact:
The BARACK – D study
If you have been told that you have Chronic Kidney Disease (reduced kidney function) then we may contact you about this study. This study is looking at a potential new treatment for preventing heart disease and kidney damage in people with Chronic Kidney Disease. However, if you meet the above criteria and are interested in helping us, you can contact:
STUDIES NOW CLOSED
Please note that recruitment has now closed for the following studies:
As always a huge thank you to everyone who has given up their valuable time to contribute to the Research Activities.
The Mail Online reports that “Diet and exercise are better than drugs at controlling type 2 diabetes”.
The Mail Online comments on a new Scottish study aiming to see whether attending a lifestyle weight management programme improves weight and blood sugar control in people with type 2 diabetes and obesity.
The study, which involved more than 20,000 adults in the Greater Glasgow and Clyde area looked at those who had type 2 diabetes and a body mass index (BMI) of 30 or above, so they would be considered clinically obese. Some (3,471) were referred to a 20-month weight management programme involving exercise advice, counselling, and a calorie-restricted diet of 600kcal per day. People were classified as completing the programme if they attended at least 8 sessions, and were considered “successful” if they lost at least 5kg.
People who successfully completed the programme (lost at least 5kg) improved their blood sugar control and didn’t need to increase their diabetes medications compared to those not referred or who didn’t successfully complete the programme.
The study generally shows that lifestyle weight management programmes can help obese people lose weight and improve their diabetes control. However, it highlights a “real world” problem of how many people would be willing to stick to the rules of the programme. In this study less than 10% of people referred successfully completed it and experienced benefits over the 3 years.
It would be useful to explore the reasons so few people successfully complete such programmes and see if there are ways they could be modified to make them more “completable” for people with type 2 diabetes and obesity.
For more information on the study, visit NHS Choices.
The National Institute for Health Research would like to understand more about patient experience of clinical research taking placing in the NHS.
Please help us by completing this anonymous questionnaire. Taking part will not affect any of your further treatment or any future participation in a research study. Your responses will help us improve the way clinical research is delivered in the NHS and will publish the findings.